During the last decades there has been a continuing evolution in the surgical approach of
squamous cell carcinoma of the vulva that has been traditionally treated with radical …

Background Vulval cancer is a rare gynaecological cancer. There is no standard approach
for treating locally advanced primary vulval cancer (FIGO stage III and IV). Combined …

Objectives: To assess early clinical outcome of intensity-modulated radiation therapy (IMRT)
in the treatment of vulvar cancer and compare dosimetric parameters with 3D conformal …

PURPOSE Treatment of vulvar carcinoma (VC) is challenging. The objectives of this review
were to describe for clinicians the epidemiologic and clinical aspects of VC, the standard of …

Vulval cancer has an incidence of 1–2/100 000. Approximately one-third of patients develop
recurrent disease usually within the first 2 years following primary treatment. Isolated vulval …

OBJECTIVE.: A twice daily (BID) radiation treatment schedule (interval of 4–6 h) delivered
concurrent with chemotherapy for advanced or critically located carcinoma of the vulva was …

OBJECTIVE. Vulvar carcinoma is a rare malignancy, most commonly seen in elderly women.
Survival depends on the lymph node status. Lymph node–negative patients have a 5-year …

Objective The advances achieved in the surgical management of vulvar squamous cell
carcinoma (SCC) have not been mirrored in systemic therapy options. The objective of this …

Introduction Treatment of locally advanced vulva cancer (LAVC) remains challenging. Due
to the lack of randomised trials many questions regarding the indications for different …

Objective. To investigate the acute and late toxicities associated with the use of
chemoradiation therapy (CRT) with 5-fluorouracil (5-FU) and mitomycin C or mitomycin C …